PAA 8.11% 20.0¢ pharmaust limited

Ann: Further Update on New Anti-Cancer Drug PPL-1 in Human Trial, page-41

  1. 2,667 Posts.
    lightbulb Created with Sketch. 111
    Very interesting, possibly one of the reasons we have a deal with the major pharma contract - could be a very profitable area. Having a major pharma by our side could be the difference in making this a succesful market ready treatment.
 
watchlist Created with Sketch. Add PAA (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.